EFS Cancer Research Results

EFS, Event-Free Survival: Click to Expand ⟱
Source:
Type:

Event-Free Survival - EFS

Type: Clinical outcome / oncology efficacy endpoint

Function: Event-Free Survival is the time from a defined starting point, such as diagnosis, treatment initiation, or randomization, until the occurrence of a prespecified adverse event. Depending on the study, events may include disease progression, relapse, treatment failure, development of a second malignancy, or death from any cause.

Cancer: ↑ Longer EFS indicates a longer period without a predefined adverse clinical event and is therefore generally favorable. ↓ EFS indicates earlier progression, relapse, treatment failure, second malignancy, death, or another protocol-defined event and is unfavorable.

Favorable Direction: ↑ Longer Event-Free Survival.

Interpretation Note: The exact definition of an "event" varies between clinical trials, so EFS values should be interpreted using the event criteria specified by the individual study.
Scientific Papers found: Click to Expand⟱
8173- Lap,  Tras,    Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials
- Review, BC, NA
CR↑, EFS↑, OS↑, toxicity↝,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

CR↑, 1,   EFS↑, 1,  

Functional Outcomes(tgid=23) ⓘ

OS↑, 1,   toxicity↝, 1,  
Total Targets: 4

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: EFS, Event-Free Survival
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1773  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page